Literature DB >> 21303237

Addressing the HIV-related needs of substance misusers in New York State: the benefits and barriers to implementing a "one-stop shopping" model.

Shiela M Strauss1, Milton Mino.   

Abstract

Substance misusers are at risk for contracting HIV/AIDS, and substance user treatment programs (SUTPs) are uniquely situated to address their HIV-related needs. In New York State, some SUTPs have implemented a centralized model of substance user treatment and HIV care. We synthesize past literature and use data from semistructured interviews with SUTP staff, analyzed with qualitative software, to describe implementation barriers. These interviews were conducted in 2003-2004 at three SUTPs in Texas and New York as part of a study funded by the National Institutes of Health. With study limitations noted, main implications include a need for a combined medical-addiction treatment philosophy to facilitate multidisciplinary care.

Entities:  

Mesh:

Year:  2011        PMID: 21303237     DOI: 10.3109/10826084.2011.521465

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  3 in total

1.  Commitment strength, alcohol dependence and HealthCall participation: effects on drinking reduction in HIV patients.

Authors:  Efrat Aharonovich; Malka Stohl; James Ellis; Paul Amrhein; Deborah Hasin
Journal:  Drug Alcohol Depend       Date:  2013-11-27       Impact factor: 4.492

Review 2.  Integrated opioid substitution therapy and HIV care: a qualitative systematic review and synthesis of client and provider experiences.

Authors:  Andy Guise; Maureen Seguin; Gitau Mburu; Susie McLean; Pippa Grenfell; Zahed Islam; Sergii Filippovych; Happy Assan; Andrea Low; Peter Vickerman; Tim Rhodes
Journal:  AIDS Care       Date:  2017-03-10

3.  Current and emerging research needs in studying the NYC HIV-drug use epidemic.

Authors:  Sherry Deren; Holly Hagan; Samuel Friedman; Don C Des Jarlais; David Perlman; Marya Gwadz; Charles Cleland; Andrew Osborne; Joseph Lunievicz
Journal:  Subst Use Misuse       Date:  2011       Impact factor: 2.164

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.